SCHEMBL15701151

SCHEMBL15701151

O=C(Cc1ccccc1)Nc1nc2ccc(NC(=O)c3cscn3)cc2s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 7/20 0.57
NFKB1 P19838 1/20 0.57
NFKB2 Q00653 1/20 0.57
RELA Q04206 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
DYRK1A Q13627 1/20 0.56
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
HSD17B10 Q99714 1/20 0.56
RAB9A P51151 5/20 0.55
MAPT P10636 5/20 0.55
POLB P06746 2/20 0.55
DYRK2 Q92630 1/20 0.52
KDM4E B2RXH2 4/20 0.52
HPGD P15428 1/20 0.51
LMNA P02545 2/20 0.49
RIPK1 Q13546 1/20 0.49
MAPK1 P28482 1/20 0.49
CASP3 P42574 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15701138 0.90 WNT3A (0.58) CSNK1DSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL15701153 0.88 CSNK1D (0.61) CSNK1DSMN1; SMN2KMT2AHSD17B10RAB9A
SCHEMBL15701111 0.88 CSNK1D (0.69) CSNK1DDYRK2RIPK1
SCHEMBL15701230 0.88 DYRK2 (0.50) CSNK1DDYRK1AALDH1A1RAB9AMAPT
SCHEMBL15701115 0.86 MAPT (0.51) CSNK1DSMN1; SMN2DYRK1AALDH1A1RAB9A
SCHEMBL15701156 0.84 RIPK1 (0.49) CSNK1DSMN1; SMN2DYRK1ARAB9AMAPT
SCHEMBL15701013 0.84 CSNK1D (0.66) CSNK1DMEN1KMT2AMAPTDYRK2
SCHEMBL17148444 0.82 CSNK1D (0.50) CSNK1DSMN1; SMN2MEN1KMT2AHSD17B10
SCHEMBL19446784 0.82 ACP1 (0.47) CSNK1DSMN1; SMN2DYRK1AALDH1A1RAB9A
SCHEMBL15701287 0.81 LMNA (0.65) CSNK1DSMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2914592-B1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INT (DE) 2017-10-11 EP disclosed
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 US disclosed
WO-2014070979-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS CDKN1A, CCNA1, IFNAR1 CSNK1D 247/4885NFKB1 677/4885NFKB2 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.